Axsome Therapeutics Total Non-Operating Income/Expense 2014-2024 | AXSM
Axsome Therapeutics total non-operating income/expense for the twelve months ending December 31, 2024 was $-0.007B, a 1.8% increase year-over-year.
- Axsome Therapeutics annual total non-operating income/expense for 2024 was $-0.007B, a 1.8% increase from 2023.
- Axsome Therapeutics annual total non-operating income/expense for 2023 was $-0.006B, a 12.02% decline from 2022.
- Axsome Therapeutics annual total non-operating income/expense for 2022 was $-0.007B, a 28.77% increase from 2021.